MFS Share Price

Open 0.02 Change Price %
High 0.02 1 Day 0.00 0.00
Low 0.02 1 Week 0.00 0.00
Close 0.02 1 Month 0.00 0.00
Volume 162800 1 Year -0.03 -60.00
52 Week High 0.08
52 Week Low 0.01
MFS Important Levels
Resistance 2 0.02
Resistance 1 0.02
Pivot 0.02
Support 1 0.02
Support 2 0.02
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
CBE 0.02 100.00%
CBE 0.02 100.00%
CBE 0.02 100.00%
NUK 0.02 100.00%
BVQ 0.02 100.00%
DDX 0.50 100.00%
DYG 0.02 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
RDM 0.21 90.91%
More..
CVE Canada Top Losers Stocks
ARH 0.00 -100.00%
ARH 0.00 -100.00%
MLR 0.02 -50.00%
MLR 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Medifocus Incorporated (CVE: MFS)

MFS Technical Analysis 5
As on 2nd Dec 2016 MFS Share Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.05 & Strong Sell for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
MFS Target for December
1st Target up-side 0.03
2nd Target up-side 0.03
3rd Target up-side 0.03
1st Target down-side 0.01
2nd Target down-side 0.01
3rd Target down-side 0.01
MFS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.medifocusinc.com
MFS Address
MFS
The Exchange Tower
Suite 1800
Toronto, ON M5X 1E3
Canada
Phone: 905-319-7070
Interactive Technical Analysis Chart Medifocus Incorporated ( MFS CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Medifocus Incorporated
MFS Business Profile
Medifocus Inc. develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-basis focused heat technology platform that utilizes natural body openings to deliver precise microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform that precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It develops APA 1000 breast cancer treatment system that is in Phase III clinical trials; and Prolieve thermodilatation system for the treatment of benign prostatic hyperplasia. The company is based in Toronto, Canada.